Company Overview and News

141
Sonoma Pharmaceuticals, Inc.'s (SNOA) CEO James Schutz on Q1 2019 Results - Earnings Call Transcript

2018-08-09 seekingalpha - 1
Good afternoon and welcome to the Sonoma Fiscal First Quarter 2019 Conference Call. My name is Chris and I will be your coordinator for today's call. At this time, all participants are in a listen-only mode. At the end of the call, we will be holding a question-and-answer session with company management. As a reminder, this call is being recorded for replay purposes.
SNOA RAD

7
Sonoma Pharmaceuticals, Inc. 2019 Q1 - Results - Earnings Call Slides

2018-08-09 seekingalpha
The following slide deck was published by Sonoma Pharmaceuticals, Inc. in conjunction with their 2019 Q1 earnings call.
SNOA

7
SNOA / Sonoma Pharmaceuticals, Inc. FORM 10-Q (Quarterly Report)

2018-08-08 sec.gov
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION
SNOA

7
SNOA / Sonoma Pharmaceuticals, Inc. FORM 8-K (Current Report)

2018-08-08 sec.gov
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549
SNOA

7
SNOA / Sonoma Pharmaceuticals, Inc. DEF 14A

2018-07-27 sec.gov
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549
SNOA

7
Sonoma Pharmaceuticals Announces First Quarter FY 2019 Financial Results and Conference Call

2018-07-25 globenewswire
PETALUMA, Calif., July 25, 2018 (GLOBE NEWSWIRE) -- Sonoma Pharmaceuticals, Inc. (Nasdaq:SNOA) today announced that financial results for its fiscal year 2019 first quarter, ended June 30, 2018, will be released after the U.S. markets close on August 8, 2018. The earnings release will be followed by a conference call at 1:30 p.m. PDT on August 8, 2018, to discuss fiscal first quarter results.
SNOA

7
SNOA / Sonoma Pharmaceuticals, Inc. DEFINITIVE PROXY STATEMENT

2018-07-17 sec.gov
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549
SNOA

17
SNOA / Sonoma Pharmaceuticals, Inc. FORM 10-K (Annual Report)

2018-06-26 sec.gov - 7
Table of Contents UNITED STATES
SNOA

10
Sonoma Pharmaceuticals, Inc.'s (SNOA) CEO James Schutz on Q4 2018 Results - Earnings Call Transcript

2018-06-14 seekingalpha
Sonoma Pharmaceuticals, Inc. (NASDAQ:SNOA) Q4 2018 Results Earnings Conference Call June 13, 2018 4:30 PM ET
SNOA

11
Sonoma Pharmaceuticals, Inc. 2018 Q4 - Results - Earnings Call Slides

2018-06-13 seekingalpha - 1
The following slide deck was published by Sonoma Pharmaceuticals, Inc. in conjunction with their 2018 Q4 earnings call.
SNOA

11
SNOA / Sonoma Pharmaceuticals, Inc. FORM 8-K (Current Report)

2018-06-13 sec.gov - 1
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549
SNOA

10
Sonoma Pharmaceuticals Reports Fiscal Year and Fourth Quarter 2018 Financial Results

2018-06-13 globenewswire
Strong Annual Year-Over-Year Growth in Revenue of 30% $10 Million in Cash as of March 31, 2018
SNOA

11
SNOA / Sonoma Pharmaceuticals, Inc. CURRENT REPORT (Current Report)

2018-06-05 sec.gov - 1
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549
SNOA

11
U.SK, dermatology arm of Brazilian NC Group, and Sonoma Pharmaceuticals Enter into License Agreement for Exclusive Rights to Sonoma’s Dermatology Products in Brazil

2018-06-05 globenewswire - 1
SAO PAULO, Brazil and PETALUMA, Calif., June 05, 2018 (GLOBE NEWSWIRE) -- U.SK Dermatology, the dermatology arm of NC Group, which besides other businesses is the largest pharmaceutical organization in Brazil both in units sold and revenues, and Sonoma Pharmaceuticals, Inc. (Nasdaq: SNOA), a specialty pharmaceutical company that develops and markets unique and effective dermatological solutions, announced today they have entered into a license and supply partnering agreement for the exclusive distribution of multiple Sonoma dermatology products into Brazil, including*:
SNOA

10
Sonoma Pharmaceuticals Announces Fiscal Year/Fourth Quarter 2018 Financial Results and Conference Call

2018-05-31 globenewswire
PETALUMA, Calif., May 31, 2018 (GLOBE NEWSWIRE) -- Sonoma Pharmaceuticals, Inc. (Nasdaq:SNOA), today announced that financial results for its fiscal fourth quarter 2018, ended March 31, 2018, will be released after the U.S. markets close on June 13, 2018. The earnings release will be followed by a conference call at 1:30 p.m. PDT on June 13, 2018, to discuss fiscal fourth quarter and year-end results.
SNOA

Related Articles

RNVA: Rennova Health Analysis and Research Report

2018-08-18 - Asif

Business overview Rennova Health, Inc. (together with its subsidiaries, “Rennova”, “we” or the “Company”) is a provider of an expanding group of health care services for healthcare providers, patients and individuals. Beginning in 2018, the Company intends to focus on and operate two synergistic divisions: 1) Clinical diagnostics through its clinical laboratories; and 2) Hospital operations through its Big South Fork Medical Center, which opened on August 8, 2017, and a hospital in Jamestown Tennessee, including a doctor’s practice, the assets of which the company expect to acquire in the second quarter of 2018, pursuant to the terms of a definitive asset purchase agreement that the company entered into on January 31, 2018, as more fully discussed below. The company believe that its approach will produce a more sustainable business model and the capture of multiple revenue streams from medical providers, patients and hospital services. Management determined that because Big So...

BLDP: Ballard Power Systems Analysis and Research Report

2018-08-13 - Asif

Core Business At Ballard, Ballard Power Systems is building a clean energy growth company. Ballard Power Systems is recognized as a world leader in proton exchange membrane (“PEM”) fuel cell power system development and commercialization. The company's principal business is the design, development, manufacture, sale and service of PEM fuel cell products for a variety of applications, focusing on its power product markets of Heavy-Duty Motive (consisting of bus, truck, rail and marine applications), Portable Power, Material Handling and Backup Power, as well as the delivery of Technology Solutions, including engineering services, technology transfer, and the license and sale of its extensive intellectual property portfolio and fundamental knowledge for a variety of fuel cell applications. A fuel cell is an environmentally clean electrochemical device that combines hydrogen fuel with oxygen (from the air) to produce electricity. The hydrogen fuel can be obtained from natural g...

MARA: Marathon Patent Group Analysis and Research Report

2018-08-13 - Asif

Overview Marathon Patent Group was incorporated in the State of Nevada on February 23, 2010 under the name Verve Ventures, Inc. On December 7, 2011, the company changed its name to American Strategic Minerals Corporation and were engaged in exploration and potential development of uranium and vanadium minerals business. In June 2012, the company discontinued its minerals business and began to invest in real estate properties in Southern California. In October 2012, the company discontinued its real estate business when its former CEO joined the firm and the company commenced its IP licensing operations, at which time the Company’s name was changed to Marathon Patent Group, Inc. On November 1, 2017, the company entered into a merger agreement with Global Bit Ventures, Inc. (“GBV”), which is focused on mining digital assets. Marathon Patent Group has since purchased its cryptocurrency mining machines and established a data center in Canada to mine digital assets. Following the me...

CUSIP: 67575P207